Beijing Huaer Pharmaceutical Joint-Stock Co., Ltd.
Beijing Huaer Pharmaceutical Joint-Stock Co., Ltd. (hereinafter referred to as “Huaer”), is a pharmaceutical company located in Beijing, China. Huaer is engaged in the research, development, production and marketing of health products, providing customers with safe and effective medical care services.
Huaer was incorporated in July 2004, beginning with a registered capital of 5 million yuan. Over the years, Huaer has boldly accepted strategic investors, injecting new capital and technology to continuously expand markets and perfect products. Currently, Huaer has three wholly-owned subsidiaries and seven holding companies nationwide. In addition, Huaer has established research and development centers in Shanghai and Wuhan, with several hundred professional technicians.
Huaers main products are concentrated on antibiotics, cardiovascular drugs, glucosemeters, reagents and control solutions, health food, and diagnostic equipment, etc. Under the tenet of “ Health is wealth ”, Huaer has adhered to science and technology innovation, developed and produced “Huaer” branded drugs, medical supplies and other products, which are all in line with international standards. All Hauers products have been approved by the State Food & Drug Administration and have passed GMP certification.
Huaer is committed to serving customers with high quality products and services. Huaer has established a strict and efficient quality control system, which has been awarded the ISO9001 certification. Furthermore, Huaer has a strong business network, having exported products as far as Africa and South America, and established long-term strategic partnerships with numerous pharmacies and major hospitals in our country.
In the future, Huaer will continue to uphold its corporate philosophy of “ To strive for excellence, creating value for customers ” and focus on technology innovation to satisfy customer needs. Huaer will strive to become the leading pharmaceutical and medical equipment manufacturer in China, and to become an internationally renowned corporate brand.
